These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 6880838)

  • 1. [Pharmacology of erythrocyte deformability].
    Marcel GA
    Acta Med Port; 1983 Apr; Suppl():55-60. PubMed ID: 6880838
    [No Abstract]   [Full Text] [Related]  

  • 2. Red cell deformability: physiological, clinical and pharmacological aspects.
    Marcel GA
    J Med; 1979; 10(5):409-16. PubMed ID: 231079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effects of vitamins E and C on erythrocytes in blood preserved in ACD solution and stored at 4 degrees C.
    Kopeć-Szlezak J; Grabarczyk M; Szczepańska I; Furman S
    Haematologia (Budap); 1988; 21(4):219-26. PubMed ID: 3209126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythrocyte adenosine triphosphate depletion during voluntary hyperventilation.
    Stäubli M; Ott P; Waber U; Stäuble UP; Jeanneret C; Peheim E; Straub PW
    J Appl Physiol (1985); 1985 Oct; 59(4):1196-200. PubMed ID: 4055597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of fructose-1, 6-diphosphate effects on erythrocytic 2, 3 diphosphoglycerate and ATP in surgical orthopedic patients.
    Urso L; Brillante C; Orlandi M; Rotundo M; Ballati S
    Agressologie; 1982; 23(3):115-7. PubMed ID: 7180979
    [No Abstract]   [Full Text] [Related]  

  • 6. [Chronic renal insufficiency undergoing conservative therapy: hemorheological pattern and erythrocytic metabolic parameters].
    Caimi G; Vaccaro F; Romano A; Serra A; Picone FP; D'Asaro S; Catania A; Sarno A
    Ric Clin Lab; 1989; 19 Suppl 1():153-7. PubMed ID: 2629077
    [No Abstract]   [Full Text] [Related]  

  • 7. Vesicle release from erythrocytes during storage and failure of rejuvenation to restore cell morphology.
    Laczkó J; Szabolcs M; Jóna I
    Haematologia (Budap); 1985; 18(4):233-48. PubMed ID: 3836159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Structural and functional properties of erythrocytes in patients with arteriosclerotic circulatory encephalopathy].
    Voloshin PV; Iavorskaia VA; Malakhov VA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(7):53-6. PubMed ID: 1661483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of nuclear magnetic resonance in a study of erythrocyte metabolism].
    Fábryová V; Goljer J; Goljer I; Zalibera L
    Vnitr Lek; 1987 Oct; 33(10):865-71. PubMed ID: 3686837
    [No Abstract]   [Full Text] [Related]  

  • 10. Significant calcium accumulation in fragile erythrocytes by dietary restriction in mice.
    Hishinuma K; Kimura S
    Int J Vitam Nutr Res; 1990; 60(4):372-8. PubMed ID: 2151662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological improvement of altered red cell deformability.
    Marcel GA
    Ric Clin Lab; 1981; 11 Suppl 1():179-88. PubMed ID: 6821316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes in erythrocyte metabolism during treatment of experimental salmonellosis poisoning].
    Tselik NI; Zakharova NB
    Patol Fiziol Eksp Ter; 1983; (6):12-4. PubMed ID: 6664688
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of 2,3-diphosphoglycerate concentration on the alkaline fragility of phosphofructokinase-deficient canine erythrocytes.
    Harvey JW; Sussman WA; Pate MG
    Comp Biochem Physiol B; 1988; 89(1):105-9. PubMed ID: 2965634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Functional nonequivalency of the erythrocytes in donor blood in relation to their acid resistance].
    Stus' LK; Loevskiĭ MM; Lipina OV; Gordienko OI; Kuraksa VM
    Gematol Transfuziol; 1988 Feb; 33(2):49-52. PubMed ID: 3371644
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacological manipulation of 2,3 DPG levels and oxygen affinity.
    Farber MO
    Prog Clin Biol Res; 1984; 165():263-77. PubMed ID: 6438646
    [No Abstract]   [Full Text] [Related]  

  • 16. [Role of the 2,3-diphosphoglycerate shunt in regulating energy metabolism in human erythrocytes].
    Kholodenko BN; Stepanchikova AV; Erlikh LI; Ataullakhanov FI; Zhabotinskiĭ AM
    Izv Akad Nauk SSSR Biol; 1985; (2):196-205. PubMed ID: 3157714
    [No Abstract]   [Full Text] [Related]  

  • 17. Erythrocyte 2,3-diphosphoglycerate and adenosine triphosphate in polycythaemia vera.
    Monti M
    Scand J Haematol; 1981 Aug; 27(2):108-10. PubMed ID: 7336161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of exogenous iron on levels of adenosinetriphosphate and 2,3-diphosphoglycerate in erythrocytes of men during extreme physical exertion].
    Pedzikiewicz J; Sobiech KA
    Med Pr; 1995; 46(5):479-84. PubMed ID: 8559053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of nifedipine and riodipine on biochemical processes in intact erythrocytes].
    Tirzite DIa; Tirzit GD; Dubur GIa
    Biull Eksp Biol Med; 1990 Oct; 110(10):379-81. PubMed ID: 2279087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythrocyte parameters during induced CA-2+-dependent rapid K+-efflux: optimum conditions for kinetic analysis.
    Szász I; Sarkadi B; Gárdos G
    Haematologia (Budap); 1974; 8(1-4):143-51. PubMed ID: 4618229
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.